(RTTNews) - Genentech, a member of the Roche Group (RHHBY), announced that the U.S. Food and Drug Administration has accepted the company's supplemental Biologics License Application or sBLA for ...
(RTTNews) - Genentech, a member of the Roche Group (RHHBY), announced new positive data from Stage 2 and Stage 3 of the National Institutes of Health (NIH)-sponsored Phase III OUtMATCH study ...
For instance, Cubist Pharmaceuticals (Cambridge, MA), whose share price jumped 17% ($0.75) following the Genentech IPO, has a new antibiotic, daptomycin, in late-stage trials in the US and Europe.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback